Page last updated: 2024-12-08

yatein

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

yatein: isolated from Anthriscus sylvestris; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dihydroanhydropodorhizol : A member of the class of butan-4-olides carrying 3,4,5-trimethoxybenzyl and (1,3-benzodioxol-5-yl)methyl substituents at positions 3 and 4 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Anthriscusgenus[no description available]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID442835
CHEMBL ID471067
CHEBI ID4553
SCHEMBL ID1037807
MeSH IDM0421795

Synonyms (33)

Synonym
2(3h)-furanone, 4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-[(3,4,5-trimethoxyphenyl)methyl]-, (3r,4r)-
rd4-6277
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]tetrahydrofuran-2-one
dihydroanhydropodorhizol
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3h)-one
40456-50-6
yatein
(-)-yatein
bdbm50241524
chebi:4553 ,
(-)-deoxypodorhizone
CHEMBL471067 ,
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
AC1L9DHE ,
2(3h)-furanone, 4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-((3,4,5-trimethoxyphenyl)methyl)-, trans-(-)-
SCHEMBL1037807
(3r,4r)-4-(1,3-benzodioxol-5-ylmethyl) dihydro-3-[(3,4,5-trimethoxyphenyl)methyl]-2(3h)-furanone
(3r,4r)-4-[(2h-1,3-benzodioxol-5-yl)methyl]-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
(3r,4r)-4-(2h-1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
2(3h)-furanone, 4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-[(3,4,5-trimethoxyphenyl)methyl]-, (3r-trans)-
(-)-trans-3-(3,4-methylenedioxybenzyl)-2-(3,4,5-trimethoxybenzyl)butyrolactone
deoxypodorhizone
GMLDZDDTZKXJLU-JKSUJKDBSA-N
(3r,4r)-4-(benzo[d][1,3]dioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3h)-one
deoxypodorhizon
DTXSID50193471
HY-N1060
CS-0016340
AKOS032948829
Q27106408
MS-26796
YTN ,
(3~{r},4~{r})-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one

Research Excerpts

Overview

Yatein is a lignan precursor of podophyllotoxin, a key agent in anticancer drugs.

ExcerptReferenceRelevance
"Yatein is a lignan precursor of podophyllotoxin, a key agent in anticancer drugs. "( Antiproliferative activity of yatein isolated from Austrocedrus chilensis against murine myeloma cells: cytological studies and chemical investigations.
Becerra, J; Ceccarelli, D; Donoso-Fierro, C; Mastrogiovanni, F; Ovidi, E; Passarella, D; PĂ©rez, C; Silva, M; Taddei, AR; Tiezzi, A; Triggiani, D, 2015
)
2.15
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".
butan-4-olideAny gamma-lactone having the lactone moiety derived from 4-hydroxybutanoic acid.
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
yatein biosynthesis II19
yatein biosynthesis I010
6-methoxypodophyllotoxin biosynthesis014
(-)-4'-demethyl-epipodophyllotoxin biosynthesis111
yatein biosynthesis II112
yatein biosynthesis I110

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 3A4Homo sapiens (human)Ki0.17700.00011.41629.9000AID589116
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ornithine decarboxylaseMus musculus (house mouse)Activity6.50000.08002.01006.5000AID377257
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID335774Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.8 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335789Antimicrobial activity against Candida albicans ATCC 10231 at 0.2 to 1 ug/ml1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335782Cytotoxicity against human HT cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID589116Mechanism based inhibition of human cytochrome P450 3A4 measured by (14C)formaldehyde production from (N-methyl-14C)-erythromycin2005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
AID377254Cytotoxicity against mouse JB6 cells by trypan blue exclusion test2000Journal of natural products, Sep, Volume: 63, Issue:9
Bioactive constituents of Thuja occidentalis.
AID335781Cytotoxicity against human Col2 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID377256Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced transformation of mouse JB6 cells after 14 days by soft agar transformation assay2000Journal of natural products, Sep, Volume: 63, Issue:9
Bioactive constituents of Thuja occidentalis.
AID335779Cytotoxicity against human A431 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID378128Inhibition of human liver microsome CYP3A4 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID335787Cytotoxicity against human ZR-75-1 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID1129936Retention time of the compound by ELSD chromatography2014Journal of natural products, Apr-25, Volume: 77, Issue:4
UPLC-MS-ELSD-PDA as a powerful dereplication tool to facilitate compound identification from small-molecule natural product libraries.
AID335772Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 20 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335783Cytotoxicity against human KBV1 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335776Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.032 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335784Cytotoxicity against human LNCAP cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335775Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.16 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335773Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 4 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335777Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.0064 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335771Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 100 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335778Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.00128 ug/mL1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID361149Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced transformation of mouse JB6 cells after 14 days by soft agar assay2002Journal of natural products, Jul, Volume: 65, Issue:7
Constituents of the twigs of Hernandia ovigera that inhibit the transformation of JB6 murine epidermal cells.
AID335769Toxicity in brine shrimp1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335786Cytotoxicity against human U373 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335770Cytotoxicity in mouse P388 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335780Cytotoxicity against human BC1 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID378129Inhibition of human liver microsome CYP2D6 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID377257Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity in mouse ME308 cells2000Journal of natural products, Sep, Volume: 63, Issue:9
Bioactive constituents of Thuja occidentalis.
AID335785Cytotoxicity against human Lu1 cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
AID335788Cytotoxicity against human KB cells1993Journal of natural products, Oct, Volume: 56, Issue:10
Cytotoxic constituents from Hyptis verticillata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.73 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]